Key Market Indicators
Norwegian sales of digestive system disorder medicines are expected to reach $403 million by 2026, a 1.2% year-on-year increase. Since 2004, the market has grown at a rate of 4.1% annually. In 2021, Norway was ranked 18th, with sales of $373 million. Austria topped the list, followed by Japan, South Korea, and Canada.
